EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Open Access · CC BY-NC 4.0

(Pro)renin, Erythropoietin, Vitamin D and Urodilatin Release From Human Donor Kidneys During Normothermic Machine Perfusion: Predictors of Early Post‐Transplant Outcome?

Hui Lin iD, Karim Bousnina iD, Julia S Slagter iD, Yitian Fang iD, Iacopo Cristoferi iD, Ingrid M Garrelds, A H Jan Danser, Marlies E J Reinders, Robert C Minnee, Martin J Hoogduijn

Clinical Transplantation · 2025-05 · 39 (5)

DOI: 10.1111/ctr.70163 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift Clinical Transplantation, online erschienen am 25.04.2025. Verfasst von Hui Lin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Vascular Medicine and Pharmacology, University Medical Center Rotterdam, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Biomarkers, Delayed Graft Function, Erythropoietin, Kidney Transplantation. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Nierstichting, Convergence Health & Technology, Astellas Pharma, Netherlands.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Human donor kidneys release (pro)renin, erythropoietin (EPO), active vitamin D, and urodilatin during normothermic machine perfusion (NMP). However, whether the endocrine function of donor kidneys is associated with post‐transplant kidney function is unclear.

Methods

We studied 28 donor kidneys, including seven from donation after brain death (DBD) donors and 21 from donation after circulatory death (DCD) donors. Prior to transplantation, we measured levels of (pro)renin, EPO, 1,25(OH) 2 D in the perfusate, and urodilatin in urine during NMP. Hormone release rates were compared between kidneys with and without delayed graft function (DGF), and correlations were assessed between hormone release rates and donor characteristics and transplant outcome, including DGF duration, serum creatinine levels at 1‐week post‐transplant, and estimated glomerular filtration rate at 1‐month post‐transplant.

Results

DBD kidneys secreted significantly less EPO and more active vitamin D than DCD kidneys. Kidneys with DGF exhibited significantly higher release rates of active vitamin D and lower release rates of urodilatin compared to those without DGF. In addition, EPO release rate was positively correlated with serum creatinine levels at 1‐week post‐transplant. Finally, urodilatin release rates were negatively correlated with DGF duration and positively correlated with urine output.

Conclusions

Urodilatin release in urine and EPO and active vitamin D release in perfusate during NMP may serve as potential biomarkers for predicting early post‐transplant outcomes. Trial Registration : ClinicalTrials.gov identifier: NCT04882254

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersDelayed Graft FunctionErythropoietinKidney TransplantationPerfusionReninVitamin DAdultFemaleHumansMaleMiddle AgedFollow-Up StudiesGlomerular Filtration RateGraft SurvivalKidney Failure, ChronicKidney Function TestsOrgan PreservationPrognosisRisk FactorsTissue Donors

Stichwörter der Autor:innen

donor kidneyearly post‐transplant outcomeendocrine functionhormone releasenormothermic machine perfusion

Substanzen

BiomarkersErythropoietinReninVitamin D

Autor:innen und Institutionen

  • Department of Internal Medicine, Vascular Medicine and Pharmacology, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Department of Internal Medicine, Erasmus MC Transplant Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Department of Surgery, Erasmus MC Transplant Institute, division of HPB & Transplant Surgery, University Medical Center Rotterdam, Rotterdam, The Netherlands.

ORCID-Profile: Hui Lin, Karim Bousnina, Julia S Slagter, Yitian Fang, Iacopo Cristoferi

Förderung

  • Nierstichting
  • Convergence Health & Technology
  • Astellas Pharma, Netherlands

Zitieren

APA

Lin, H., Bousnina, K., Slagter, J. S., Fang, Y., Cristoferi, I., Garrelds, I. M., Danser, A. H. J., Reinders, M. E. J., Minnee, R. C., & Hoogduijn, M. J. (2025). (Pro)renin, Erythropoietin, Vitamin D and Urodilatin Release From Human Donor Kidneys During Normothermic Machine Perfusion: Predictors of Early Post‐Transplant Outcome?. Clinical Transplantation, 39(5). https://doi.org/10.1111/ctr.70163

Vancouver

Lin H, Bousnina K, Slagter JS, Fang Y, Cristoferi I, Garrelds IM, et al. (Pro)renin, Erythropoietin, Vitamin D and Urodilatin Release From Human Donor Kidneys During Normothermic Machine Perfusion: Predictors of Early Post‐Transplant Outcome?. Clinical Transplantation. 2025;39(5). doi:10.1111/ctr.70163

BibTeX
@article{Lin2025,
  author = {Lin, Hui and Bousnina, Karim and Slagter, Julia S and Fang, Yitian and Cristoferi, Iacopo and Garrelds, Ingrid M and Danser, A H Jan and Reinders, Marlies E J and Minnee, Robert C and Hoogduijn, Martin J},
  title = {(Pro)renin, Erythropoietin, Vitamin D and Urodilatin Release From Human Donor Kidneys During Normothermic Machine Perfusion: Predictors of Early Post‐Transplant Outcome?},
  journal = {Clinical Transplantation},
  year = {2025},
  volume = {39},
  number = {5},
  doi = {10.1111/ctr.70163}
}
Kostenlos starten →